Scott has helped over a dozen biopharma companies improve their commercial strategies and decisions through heightened market insights driven by rigorous data analysis.

Scott has seven years of healthcare consulting experience focused on biopharmaceutical marketing and insights. His current passion is oncology marketing. He is also a core member of ZS’s biosimilars vertical.

Over his five years at ZS, Scott has worked with more than a dozen biopharma clients to help them improve their marketing and sales strategies and overall commercial effectiveness. He has worked extensively in HCP segmentation and targeting, new product launch planning, go-to-market positioning and value proposition framing, marketing mix impact assessment, patient treatment flow, customer insights and biosimilar competitive strategies

Prior to joining ZS, Scott was a senior consultant with Capgemini Consulting in the firm’s life sciences practice. Before that, he worked in the global public health space for think tanks and policy research organizations.

Scott holds an MBA with honors from the Kellogg School of Management at Northwestern University and a B.A. with honors from Tufts University in economics and international relations.